$XENE Income Statement | Understand Stock

$XENE

$35.77 +$0.43 (1.22%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Collaboration revenue (note 10)
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Unrealized fair value gain (loss) on marketable securities
Unrealized fair value gain on trading securities
Foreign exchange gain (loss)
Loss on repayment of term loan (note 11)
Total other income
Loss before income taxes
Income tax recovery (expense) (note 14)
Net loss
Net loss attributable to preferred shareholders
Net loss attributable to common shareholders

Other comprehensive income (loss):
Unrealized gain (loss) on available-for-sale securities (note 5)
Comprehensive loss
Net loss per common share (note 11):
Basic and diluted
Basic and diluted
Basic
Diluted
Weighted average common shares outstanding (note 11):
Basic
Diluted

Comments